Joseph Bonventre

Dr. Bonventre holds appointments as Chief of both the Renal Division and the Founding Chief of the Biomedical Engineering Division at a large academic medical center. He runs a large, productive research lab focused on kidney injury, repair, and signal transduction and has over 300 peer-reviewed publications and 150 invited book chapters and reviews. He is past president of the American Society for Nephrology, received two MERIT awards from the NIH, and has been elected to the American Society of Clinical Investigation, the Association of American Physicians, and the American Institute for Medical and Biological Engineering. He served as director of the Harvard-MIT Health Sciences and Technology program for 10 years and was the founding head of the Kidney Group and is now on the Executive Committee of the Harvard Stem Cell Institute. He served on the Board of Directors of AMAG Pharmaceuticals and has been a Founding Board of Directors member of the National Space Biology Research Institute. He is also the co-founder of two companies and an advisor to a number of other pharmaceutical and biotechnology companies.

In addition to his BS with distinction in Engineering Physics from Cornell, Dr. Bonventre holds MD and Ph.D. degrees from Harvard University and honorary degrees from Mt. Saint Mary’s College and from the Norwegian Institute of Science and Technology.